Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$0.99
NASDAQLPCN
Open
$0.93
Change
$0.09 (10.08%)
Day's Range
$0.90 - $1.01
52-Week Range
$0.31 - $3.46
Volume
1.0M
Market Cap
$47.3M